Skip to content

Clinical trials

Osteoporosis, Postmenopausal trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis, Postmenopausal Country / region: Canada Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20023
20043
20051
20062
20072
20082
20091
20111
20124
20131
20141
20171
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company8
Amgen5
Warner Chilcott3
Hoffmann-La Roche2
Novartis Pharmaceuticals2
Sanofi2
Groupe De Recherche En Rhumatologie Et Maladies Osseuses Inc.1
McMaster University1
University Health Network, Toronto1
University of Calgary1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis, Postmenopausal26
Osteoporosis12
Bone Diseases, Metabolic5
Bone Diseases2
Musculoskeletal Diseases2
Spinal Fractures2
Back Pain1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.